SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-006726
Filing Date
2022-09-19
Accepted
2022-09-19 16:06:37
Documents
1
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6744
  Complete submission text file 0001562180-22-006726.txt   8133
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 100 BINNEY STREET SUITE 610 CAMBRIDGE MA 02142
Business Address
GOTTSCHALK ADRIAN (Reporting) CIK: 0001828724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39634 | Film No.: 221250685